Genetic basis of kidney cancer: a model for developing molecular-targeted therapies

BJU Int. 2007 May;99(5 Pt B):1223-9. doi: 10.1111/j.1464-410X.2007.06814.x.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural
  • Review

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / therapeutic use*
  • Benzenesulfonates / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / genetics*
  • Humans
  • Indoles / therapeutic use*
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / genetics*
  • Leiomyomatosis / genetics
  • Middle Aged
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Pyridines / therapeutic use*
  • Pyrroles / therapeutic use*
  • Sorafenib
  • Sunitinib
  • von Hippel-Lindau Disease / genetics

Substances

  • Antineoplastic Agents
  • Benzenesulfonates
  • Indoles
  • Phenylurea Compounds
  • Pyridines
  • Pyrroles
  • Niacinamide
  • Sorafenib
  • Sunitinib